Aushon Enters Predictive Dx Deal with Peking University

The partners will use Aushon's technology to develop predictive diagnostic markers for liver metastases of colorectal cancer.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.